Literature DB >> 33495460

Caveolae-mediated Tie2 signaling contributes to CCM pathogenesis in a brain endothelial cell-specific Pdcd10-deficient mouse model.

Lingfeng Qin1, Quan Jiang1, Katie N Murray2, Haifeng Zhang1, Huanjiao Jenny Zhou3, Busu Li1, Qun Lin1, Morven Graham4, Xinran Liu4, Jaime Grutzendler2, Wang Min5.   

Abstract

Cerebral cavernous malformations (CCMs) are vascular abnormalities that primarily occur in adulthood and cause cerebral hemorrhage, stroke, and seizures. CCMs are thought to be initiated by endothelial cell (EC) loss of any one of the three Ccm genes: CCM1 (KRIT1), CCM2 (OSM), or CCM3 (PDCD10). Here we report that mice with a brain EC-specific deletion of Pdcd10 (Pdcd10BECKO) survive up to 6-12 months and develop bona fide CCM lesions in all regions of brain, allowing us to visualize the vascular dynamics of CCM lesions using transcranial two-photon microscopy. This approach reveals that CCMs initiate from protrusion at the level of capillary and post-capillary venules with gradual dissociation of pericytes. Microvascular beds in lesions are hyper-permeable, and these disorganized structures present endomucin-positive ECs and α-smooth muscle actin-positive pericytes. Caveolae in the endothelium of Pdcd10BECKO lesions are drastically increased, enhancing Tie2 signaling in Ccm3-deficient ECs. Moreover, genetic deletion of caveolin-1 or pharmacological blockade of Tie2 signaling effectively normalizes microvascular structure and barrier function with attenuated EC-pericyte disassociation and CCM lesion formation in Pdcd10BECKO mice. Our study establishes a chronic CCM model and uncovers a mechanism by which CCM3 mutation-induced caveolae-Tie2 signaling contributes to CCM pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33495460      PMCID: PMC7835246          DOI: 10.1038/s41467-020-20774-0

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  76 in total

1.  A network of interactions enables CCM3 and STK24 to coordinate UNC13D-driven vesicle exocytosis in neutrophils.

Authors:  Yong Zhang; Wenwen Tang; Haifeng Zhang; Xiaofeng Niu; Yingke Xu; Jiasheng Zhang; Kun Gao; Weijun Pan; Titus J Boggon; Derek Toomre; Wang Min; Dianqing Wu
Journal:  Dev Cell       Date:  2013-10-28       Impact factor: 12.270

2.  Central nervous system pericytes in health and disease.

Authors:  Ethan A Winkler; Robert D Bell; Berislav V Zlokovic
Journal:  Nat Neurosci       Date:  2011-10-26       Impact factor: 24.884

3.  Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations.

Authors:  Nisha Limaye; Vinciane Wouters; Melanie Uebelhoer; Marjut Tuominen; Riikka Wirkkala; John B Mulliken; Lauri Eklund; Laurence M Boon; Miikka Vikkula
Journal:  Nat Genet       Date:  2008-12-14       Impact factor: 38.330

4.  Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects.

Authors:  Elisa Boscolo; Nisha Limaye; Lan Huang; Kyu-Tae Kang; Julie Soblet; Melanie Uebelhoer; Antonella Mendola; Marjut Natynki; Emmanuel Seront; Sophie Dupont; Jennifer Hammer; Catherine Legrand; Carlo Brugnara; Lauri Eklund; Miikka Vikkula; Joyce Bischoff; Laurence M Boon
Journal:  J Clin Invest       Date:  2015-08-10       Impact factor: 14.808

5.  Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta 1.

Authors:  M M Verbeek; I Otte-Höller; P Wesseling; D J Ruiter; R M de Waal
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

6.  Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling.

Authors:  Moritz Felcht; Robert Luck; Alexander Schering; Philipp Seidel; Kshitij Srivastava; Junhao Hu; Arne Bartol; Yvonne Kienast; Christiane Vettel; Elias K Loos; Simone Kutschera; Susanne Bartels; Sila Appak; Eva Besemfelder; Dorothee Terhardt; Emmanouil Chavakis; Thomas Wieland; Christian Klein; Markus Thomas; Akiyoshi Uemura; Sergij Goerdt; Hellmut G Augustin
Journal:  J Clin Invest       Date:  2012-05-15       Impact factor: 14.808

7.  Endothelial cell clonal expansion in the development of cerebral cavernous malformations.

Authors:  Matteo Malinverno; Claudio Maderna; Abdallah Abu Taha; Monica Corada; Fabrizio Orsenigo; Mariaelena Valentino; Federica Pisati; Carmela Fusco; Paolo Graziano; Monica Giannotta; Qing Cissy Yu; Yi Arial Zeng; Maria Grazia Lampugnani; Peetra U Magnusson; Elisabetta Dejana
Journal:  Nat Commun       Date:  2019-06-24       Impact factor: 14.919

8.  A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.

Authors:  Axel Pagenstecher; Sonja Stahl; Ulrich Sure; Ute Felbor
Journal:  Hum Mol Genet       Date:  2008-12-16       Impact factor: 6.150

9.  A molecular atlas of cell types and zonation in the brain vasculature.

Authors:  Michael Vanlandewijck; Liqun He; Maarja Andaloussi Mäe; Johanna Andrae; Koji Ando; Francesca Del Gaudio; Khayrun Nahar; Thibaud Lebouvier; Bàrbara Laviña; Leonor Gouveia; Ying Sun; Elisabeth Raschperger; Markus Räsänen; Yvette Zarb; Naoki Mochizuki; Annika Keller; Urban Lendahl; Christer Betsholtz
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

10.  Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.

Authors:  Zinan Zhou; Alan T Tang; Weng-Yew Wong; Sharika Bamezai; Lauren M Goddard; Robert Shenkar; Su Zhou; Jisheng Yang; Alexander C Wright; Matthew Foley; J Simon C Arthur; Kevin J Whitehead; Issam A Awad; Dean Y Li; Xiangjian Zheng; Mark L Kahn
Journal:  Nature       Date:  2016-03-30       Impact factor: 49.962

View more
  4 in total

1.  CCM3 Loss-Induced Lymphatic Defect Is Mediated by the Augmented VEGFR3-ERK1/2 Signaling.

Authors:  Lingfeng Qin; Haifeng Zhang; Busu Li; Quan Jiang; Francesc Lopez; Wang Min; Jenny Huanjiao Zhou
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-10-21       Impact factor: 8.311

Review 2.  Cerebral Cavernous Malformation Pathogenesis: Investigating Lesion Formation and Progression with Animal Models.

Authors:  Chelsea M Phillips; Svetlana M Stamatovic; Richard F Keep; Anuska V Andjelkovic
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

3.  A murine model of cerebral cavernous malformations with acute hemorrhage.

Authors:  Claudio Maderna; Federica Pisati; Claudio Tripodo; Elisabetta Dejana; Matteo Malinverno
Journal:  iScience       Date:  2022-02-18

Review 4.  Cerebral Cavernous Malformation: Immune and Inflammatory Perspectives.

Authors:  Tianqi Tu; Zhenghong Peng; Jian Ren; Hongqi Zhang
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.